Marion Odence-Ford - 11 Feb 2023 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
General Counsel and CCO
Signature
/s/ Marion Odence-Ford
Issuer symbol
OPRX
Transactions as of
11 Feb 2023
Net transactions value
-$24,657
Form type
4
Filing time
14 Feb 2023, 10:32:14 UTC
Previous filing
10 Nov 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Options Exercise $0 +4,000 +66% $0.000000 10,075 11 Feb 2023 Direct F1
transaction OPRX Common Stock Tax liability $24,657 -1,422 -14% $17.34 8,653 11 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Options Exercise $0 -4,000 -25% $0.000000 12,000 11 Feb 2023 Common Stock 4,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
F3 On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date